The Journal of antimicrobial chemotherapyHumansSilicatesTrimethoprimSulfamethoxazole Drug CombinationMale
Evaluation of sodium zirconium cyclosilicate usage for hyperkalaemia secondary to sulfamethoxazole/trimethoprim therapy.
Dixie Pyles, Nicole Kovacic Scherrer, Erika Zarfoss Ponce, Amanda Jo Shigle
Published: 202510.1093/jac/dkaf380
Abstract
BACKGROUND: Sulfamethoxazole/trimethoprim is utilized to treat various infections, but its use can be limited by hyperkalaemia. Sodium zirconium cyclosilicate is a potassium binder, which has been shown to lower potassium in chronic kidney disease. O…
Preview only. Read the full abstract at the source